New vaccine platform may make virus-fighting easier

New vaccine platform may make virus-fighting easier

3D print of HIV surface protein gp120. An antibody also is attached at the top (green and blue). When antibodies stick to viruses, they may prevent or limit infection of host cells. CREDIT: NIH To many, EV stands for “electric vehicle.” To researchers at Harvard...
FDA panel recommends new COVID vaccine approach

FDA panel recommends new COVID vaccine approach

The Food and Drug Administration (FDA) vaccine advisory group today recommended streamlining COVID-19 vaccine campaigns by offering just the newer bivalent (two-strain) versions of the vaccine for both primary and booster series. The measure, which passed unanimously,...
FDA panel eyes shift to annual COVID shots

FDA panel eyes shift to annual COVID shots

In a document posted ahead of an advisory group meeting on Jan 26, the US Food and Drug Administration (FDA) today spelled out a proposal for annual COVID-19 vaccine shots for the majority of people and a system for updating the vaccines that mirrors that for flu...
Developing mucosal vaccines for respiratory viruses

Developing mucosal vaccines for respiratory viruses

Creative work featuring 3D renditions of three dangerous respiratory viruses: RSV (left), influenza (center), and SARS-CoV-2 (right). Note: Not to scale. CREDIT: NIAID Vaccines that provide long-lasting protection against influenza, coronaviruses and respiratory...
Scientists develop vax to kill, prevent brain cancer

Scientists develop vax to kill, prevent brain cancer

Scientists developed a bifunctional therapeutic strategy by transforming living tumor cells into a therapeutic, using the gene editing tool CRISPR-Cas9 and repurposing them to release tumor cell killing agent. In addition, the engineered tumor cells were designed to...